IM Cannabis Corp.

CNSX: IMCC


Canadian symbol: IMCC.CN
US symbol: IMCC

Currency in CAD

Valuation Measures4

Market Cap (intraday) 7.10M
Enterprise Value 17.48M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.14
Price/Book (mrq)0.37
Enterprise Value/Revenue 0.33
Enterprise Value/EBITDA -1.02

Trading Information

Stock Price History

Beta (5Y Monthly) 1.82
52-Week Change 3-75.12%
S&P500 52-Week Change 315.38%
52 Week High 32.3600
52 Week Low 30.4750
50-Day Moving Average 30.6826
200-Day Moving Average 31.0117

Share Statistics

Avg Vol (3 month) 32.48k
Avg Vol (10 day) 32.85k
Shares Outstanding 513.39M
Implied Shares Outstanding 613.39M
Float 88.56M
% Held by Insiders 136.09%
% Held by Institutions 111.18%
Shares Short (Nov 14, 2023) 41.07k
Short Ratio (Nov 14, 2023) 40.97
Short % of Float (Nov 14, 2023) 40.01%
Short % of Shares Outstanding (Nov 14, 2023) 40.01%
Shares Short (prior month Oct 12, 2023) 43.6k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Nov 16, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Sept 29, 2023

Profitability

Profit Margin -74.64%
Operating Margin (ttm)-18.26%

Management Effectiveness

Return on Assets (ttm)-7.15%
Return on Equity (ttm)-43.18%

Income Statement

Revenue (ttm)52.57M
Revenue Per Share (ttm)4.62
Quarterly Revenue Growth (yoy)-12.70%
Gross Profit (ttm)9.16M
EBITDA -7.54M
Net Income Avi to Common (ttm)-15.44M
Diluted EPS (ttm)-3.9100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.3M
Total Cash Per Share (mrq)0.1
Total Debt (mrq)11.68M
Total Debt/Equity (mrq)59.01%
Current Ratio (mrq)1.01
Book Value Per Share (mrq)1.43

Cash Flow Statement

Operating Cash Flow (ttm)-10.37M
Levered Free Cash Flow (ttm)15.3M

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
IMCC.CN
IM Cannabis
2 days ago
IMCC.CN
IM Cannabis
1 week ago
IMCC.CN
IM Cannabis
1 week ago
IMCC.CN
IM Cannabis
3 weeks ago
IMCC.CN
IM Cannabis
3 weeks ago
IMCC.CN
IM Cannabis
3 weeks ago
IMCC.CN
IM Cannabis
3 weeks ago
IMCC.CN
IM Cannabis
3 weeks ago
IMCC.CN
IM Cannabis
3 weeks ago
IMCC.CN
IM Cannabis
2 months ago
IMCC.CN
IM Cannabis
2 months ago
IMCC.CN
IM Cannabis
2 months ago
IMCC.CN
IM Cannabis
2 months ago
IMCC.CN
IM Cannabis
2 months ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
3 months ago
IMCC.CN
IM Cannabis
4 months ago
IMCC.CN
IM Cannabis
4 months ago
IMCC.CN
IM Cannabis
4 months ago
IMCC.CN
IM Cannabis
4 months ago
IMCC.CN
IM Cannabis
4 months ago
IMCC.CN
IM Cannabis
4 months ago
IMCC.CN
IM Cannabis
5 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
6 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
7 months ago
IMCC.CN
IM Cannabis
8 months ago
IMCC.CN
IM Cannabis
8 months ago
IMCC.CN
IM Cannabis
8 months ago
IMCC.CN
IM Cannabis
8 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
9 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
10 months ago
IMCC.CN
IM Cannabis
11 months ago
IMCC.CN
IM Cannabis
11 months ago
IMCC.CN
IM Cannabis
11 months ago
IMCC.CN
IM Cannabis
11 months ago
IMCC.CN
IM Cannabis
11 months ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
1 year ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
2 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
3 years ago
IMCC.CN
IM Cannabis
4 years ago
IMCC.CN
IM Cannabis
4 years ago
IMCC.CN
IM Cannabis
4 years ago

Currency in CAD
Earnings EstimateCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
No. of Analysts1111
Avg. Estimate-0.06-0.04-0.530.02
Low Estimate-0.06-0.04-0.530.02
High Estimate-0.06-0.04-0.530.02
Year Ago EPS-0.06-0.21-0.31-0.53
Revenue EstimateCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
No. of Analysts1111
Avg. Estimate25.3M27.3M100M137.5M
Low Estimate25.3M27.3M100M137.5M
High Estimate25.3M27.3M100M137.5M
Year Ago Sales18.75M8.3M54.3M100M
Sales Growth (year/est)34.90%228.90%84.20%37.50%
Earnings History2021-09-292021-12-302022-03-302022-06-29
EPS Est.-0.02-0.04-0.010.05
EPS Actual-0.06-0.21-0.14-0.3
Difference-0.04-0.17-0.13-0.35
Surprise %-200.00%-425.00%-1,300.00%-700.00%
EPS TrendCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
Current Estimate-0.06-0.04-0.530.02
7 Days Ago-0.06-0.04-0.530.02
30 Days Ago-0.06-0.04-0.530.02
60 Days Ago-0.06-0.04-0.530.02
90 Days Ago0.060.070.170.38
EPS RevisionsCurrent Qtr. (Sep 2022)Next Qtr. (Dec 2022)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesIMCC.CNIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.81.00%N/AN/AN/A
Current Year-71.00%N/AN/AN/A
Next Year103.80%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
36.09%% of Shares Held by All Insider
11.18%% of Shares Held by Institutions
17.50%% of Float Held by Institutions
21Number of Institutions Holding Shares

Top Institutional Holders

HolderSharesDate Reported% OutValue
Lynwood Capital Management Inc.650,000Sept 29, 20234.85%344,499
Black Maple Capital Management Lp410,000Sept 29, 20233.06%217,299
AdvisorShares Investments, LLC230,860Sept 29, 20231.72%122,355
Bank of Montreal/Can/75,522Sept 29, 20230.56%40,026
Renaissance Technologies, LLC23,100Sept 29, 20230.17%12,242
Citadel Advisors Llc23,033Sept 29, 20230.17%12,207
EMC Capital Management8,688Sept 29, 20230.06%4,604
Toronto Dominion Bank2,830Sept 29, 20230.02%1,499
Concord Wealth Partners500Sept 29, 20230.00%264
National Bank of Canada/FI98Sept 29, 20230.00%51

Top Mutual Fund Holders

HolderSharesDate Reported% OutValue
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF230,860Sept 29, 20231.72%122,355
Amplify Seymour Cannabis ETF9,600Jul 30, 20230.07%5,087
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by IM Cannabis Corp.


New Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in November 2023 USA - English Israel - English

New Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in November 2023 USA – English Israel – English

TORONTO and GLIL YAM, Israel, Dec. 8, 2023 -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing a 3-month delay of the anticipated medical cannabis reform announced by the Israeli ministry of health on August 7, 2023 (the "Reform")... Read More...
IM Cannabis Announces Receipt of Court Action

IM Cannabis Announces Receipt of Court Action

TORONTO and GLIL YAM, Israel, Nov. 27, 2023 -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany announces that a complaint was in the Ontario Superior Court of Justice in Canada by Michael Wiener, 35 Oak Holdings Ltd. and MW Investments Ltd. (co... Read More...
IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET

IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET

TORONTO and GLIL YAM, Israel, Nov. 8, 2023 -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended September 30, 2023, on Monday, November 13, 2023 before the... Read More...
IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt

IM Cannabis Releases a Message from the CEO about the Israel-Hamas War and announces securing C$1,390,000 in Short-Term Debt

TORONTO and GLIL YAM, Israel, Oct. 13, 2023 -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany releases message from Chief Executive Officer about the Israel-Hamas War and announces the Company, through its wholly-owned subsidiaries, IMC Holdin... Read More...
IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer

IM Cannabis Announces the appointment of Uri Birenberg as Chief Financial Officer

TORONTO and GLIL YAM, Israel, Oct. 10, 2023 -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is pleased to announce that Uri Birenberg will join the company's leadership team as Chief Financial Officer effective October 10, 20... Read More...
IM Cannabis Announces CFO Departure

IM Cannabis Announces CFO Departure

TORONTO and GLIL YAM, Israel, Sept. 19, 2023 -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading international medical cannabis company with operations in Israel and Germany, today announced that Itay Vago, the Company's Chief Financial Officer, has decided to leave the Company for personal r... Read More...
IMC welcomes new Israeli cannabis regulations which are about to change significantly, facilitating access for many new patients

IMC welcomes new Israeli cannabis regulations which are about to change significantly, facilitating access for many new patients

The Israeli ministry of health announced the anticipated medical cannabis regulatory reform on Monday August 7, 2023. The new regulations will remove many of the heavy regulations in the sector, making medical cannabis more accessible to patients as well as boosting export. TORONTO and GLIL YAM, Israel, Aug. 11, 2023 -- IM Cannabis Corp.... Read More...
IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET

IM Cannabis to Report Second Quarter 2023 Financial Results on Monday, August 14 at 9:00am ET

TORONTO and GLIL YAM, Israel, Aug. 8, 2023 -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended June 30, 2023, on Monday, August 14, 2023 before the market... Read More...
IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement

IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq’s Minimum Bid Price Requirement

TORONTO and GLIL YAM, Israel, June 13, 2023 -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, today announced that on June 12, 2023, it has received formal notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Co... Read More...
IM Cannabis Reports First Quarter 2023 Financial Results; Gross Profit Increased 46% Year-over-Year

IM Cannabis Reports First Quarter 2023 Financial Results; Gross Profit Increased 46% Year-over-Year

IMC leans further into its strategy, continuing to focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets, while accelerating its path to profitability through active cost management and margin improvement. TORONTO and GLIL YAM, Israel, May 15, 2023 -- IM Cannabis Corp.... Read More...
IM Cannabis to Report First Quarter 2023 Financial Results on Monday, May 15 at 9:00am ET

IM Cannabis to Report First Quarter 2023 Financial Results on Monday, May 15 at 9:00am ET

TORONTO and GLIL YAM, Israel, May 8, 2023 -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the first quarter ended March 31, 2023, on Monday, May 15, 2023 before the market ope... Read More...
IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

IM Cannabis Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Revenues in 2022 Increased 60% Year-over-Year

Company to continue its focus on the Israeli and German markets with a primary goal of sustainably increasing revenue in each of these core markets and accelerating path to profitability, while actively managing costs and margins TORONTO, and GLIL YAM, Israel, March 29, 2023 -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CS... Read More...
IM Cannabis to Report Fourth Quarter & Full Year 2022 Financial Results on Wednesday, March 29 at 9:00am ET

IM Cannabis to Report Fourth Quarter & Full Year 2022 Financial Results on Wednesday, March 29 at 9:00am ET

TORONTO and GLIL YAM, Israel, March 15, 2023 -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2022 on Wednesday, March 29, 2023, before the market opens. The... Read More...
IM Cannabis Announces Additional Restructuring Initiatives Designed to Drive Sustainable Profitability and Reduce Costs

IM Cannabis Announces Additional Restructuring Initiatives Designed to Drive Sustainable Profitability and Reduce Costs

The Company aims for a leaner organization with a primary focus on achieving profitability in 2023 and approximately CAD$3.5 million in annualized cost savings TORONTO and GLIL YAM, Israel, March 8, 2023 -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, today announced a ... Read More...
IM Cannabis Closes Additional Tranches of Private Placement Offerings

IM Cannabis Closes Additional Tranches of Private Placement Offerings

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO and GLIL YAM, Israel, Feb. 7, 2023 -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce that it has closed a fourth tranche of its previously annou... Read More...
IM Cannabis Closes Second Tranche of Private Placement Offerings

IM Cannabis Closes Second Tranche of Private Placement Offerings

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO and GLIL YAM, Israel, Jan. 20, 2023 -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce that it has closed a second tranche of its previously anno... Read More...
IM Cannabis Closes First Tranche of Non-Brokered Listed Issuer Financing Exemption Offering and its Concurrent Offering

IM Cannabis Closes First Tranche of Non-Brokered Listed Issuer Financing Exemption Offering and its Concurrent Offering

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO and GLIL YAM, Israel, Jan. 16, 2023 -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, is pleased to announce that it has closed the first tranche of its non-brokered p... Read More...
IM Cannabis Common Shares Commence Trading on Consolidated Basis After 1 for 10 Reverse Stock Split

IM Cannabis Common Shares Commence Trading on Consolidated Basis After 1 for 10 Reverse Stock Split

GLIL YAM, Israel, Nov. 17, 2022 -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced today that  further to the press release dated November 14, 2022, all of its issued and outstanding common shares ("Common Shares") began trading on the Canadian Securities Exchange... Read More...
IM Cannabis Reports Third Quarter 2022 Financial Results; Revenues Increased 78% YoY and 12% Sequentially

IM Cannabis Reports Third Quarter 2022 Financial Results; Revenues Increased 78% YoY and 12% Sequentially

Company to refocus resources and efforts on the Israeli and German markets; Commences exit of the Canadian market TORONTO and GLIL YAM, Israel, Nov. 14, 2022 -- IM Cannabis Corp. (the "Company", "IM Cannabis", or "IMC") (CSE: IMCC) (NASDAQ: IMCC), a leading medical cannabis company, provided financial results for its third quarter ended ... Read More...
IM Cannabis to Focus on Israel, German and European Growth; Commences Exiting the Canadian Cannabis Market

IM Cannabis to Focus on Israel, German and European Growth; Commences Exiting the Canadian Cannabis Market

The company will focus its efforts and resources on growth in Israel and Germany, with a primary focus of achieving profitability in 2023 Trichome Financial Corp. and certain of its subsidiaries have obtained protection from creditors pursuant to the Companies' Creditors Arrangement Act ("CCAA") GLIL YAM, Israel, Nov. 7, 2022 -- IM Cannab... Read More...
IM Cannabis Closes Second Tranche of Non-Brokered Private Placement of Common Shares

IM Cannabis Closes Second Tranche of Non-Brokered Private Placement of Common Shares

Marc Lustig, Executive Chairman of the Company Subscribes for 1,112,504 common shares at USD$0.50 TORONTO and GLIL YAM, Israel, Oct. 6, 2022 -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, is plea... Read More...
SNDL and IM Cannabis Complete SNDL's First International Export of Premium Dried Flower from Canada to Israel

SNDL and IM Cannabis Complete SNDL’s First International Export of Premium Dried Flower from Canada to Israel

CALGARY, AB and GLIL YAM, Israel, Sept. 15, 2022 - SNDL Inc. (Nasdaq: SNDL) ("SNDL" or the "Company"), Canada's largest regulated products platform, and IM Cannabis Corp. (Nasdaq: IMCC) (CSE: IMCC) ("IMC"), today announced that SNDL has completed its initial international export of approximately 167 kilograms of premium dried flower from ... Read More...
IM Cannabis Closes First Tranche of Non-Brokered Private Placement of Common Shares

IM Cannabis Closes First Tranche of Non-Brokered Private Placement of Common Shares

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO and GLIL YAM, Israel, Aug. 24, 2022 - IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, is pl... Read More...
IM Cannabis Announces USD$5,000,000 Private Placement Led by Management

IM Cannabis Announces USD$5,000,000 Private Placement Led by Management

TORONTO, ONTARIO, Canada and GLIL YAM, Israel, Aug. 19, 2022 -- IM Cannabis Corp. ("IM Cannabis" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, is pleased to announce that it is undertaking a non-brokered private placement for aggr... Read More...
IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 Million

IM Cannabis Reports Record Second Quarter 2022 Financial Results; Revenues Increase 114% YoY to $23.8 Million

Gross margin of 24%, which is expected to increase with further asset integration, product availability, and operational improvements Approximately $6.5 million per year in expected cash cost savings from streamlining operations in Canada and closure of Israeli cultivation farm TORONTO and GLIL YAM, Israel, Aug. 15, 2022 -- IM Cannabis C... Read More...
IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9:00am ET

IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9:00am ET

TORONTO and GLIL YAM, Israel, Aug. 4, 2022 -- IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, will report operational and financial results for the second quarter ended June 30, 2022, on Monday, Augu... Read More...
IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million

IM Cannabis Reports Record First Quarter 2022 Financial Results; Revenues Increase 169% YoY to $23.6 Million

Gross Profit Increased 37% from Q1 2021 as Operational Efficiencies from Integration Take Hold; Company Expects to Achieve Positive Adjusted EBITDA in Q2 2022 TORONTO and GLIL YAM, Israel, May 12, 2022 -- IM Cannabis Corp. (the "Company", "IM Cannabis", or "IMC") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational can... Read More...
IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries

IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries

Closure of Sde Avraham farm in Israel optimizes Company's organizational structure by fully leveraging global import-export supply chain Increase in Revolving Credit Facility availability to $15 million supports increased global demand for premium cannabis TORONTO, Canada and GLIL YAM, Israel , April 6, 2022 -- IM Cannabis Corp. (the "Com... Read More...
IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook

IM Cannabis Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results and Provides First Quarter 2022 Outlook

- Fiscal Year 2021 revenues increased 242% year-over-year to a record of over $54 million - Q4 2021 revenues increased 309% year-over-year and 39% compared to Q3 2021 - Sequential revenue growth and gross margin improvement expected in Q1 2022 TORONTO, and GLIL YAM, Israel, March 31, 2022 -- IM Cannabis Corp. (the "Company", "IM Cannabi... Read More...
IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem's Leading Medical Cannabis Pharmacy

IM Cannabis Closes Previously Announced Acquisition of Oranim Pharm, Jerusalem’s Leading Medical Cannabis Pharmacy

Transaction expands IMC's footprint into Israel's largest city while positioning the Company as one of the largest retailers of medical cannabis in the country TORONTO, and GLIL YAM, Israel, March 30, 2022 -- IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabi... Read More...
IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results

IM Cannabis Reports Record Preliminary Fourth Quarter and Full Year 2021 Financial Results

TORONTO and GLIL YAM, Israel, March 10, 2022 -- IM Cannabis Corp. (the "Company", "IM Cannabis", or "IMC") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, provided preliminary unaudited financial results for the three months and fiscal year ended Dec... Read More...
IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor rela... Read More...
IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

IM Cannabis announces Focus Medical’s Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

The successful import demonstrates the strength of the IM Cannabis global supply chain and business modelTORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 19, 2022 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Can... Read More...
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company's Israeli Subsidiary

IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary

Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp.TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 13, 2022 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMC... Read More...
IM Cannabis to Launch WAGNERS Brand in Germany

IM Cannabis to Launch WAGNERS Brand in Germany

IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis marketTORONTO, ON, GLIL YAM, ISRAEL and BAD OLDESLOE, GERMANY / ACCESSWIRE / December 7, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a global cannabis company with operations ... Read More...
Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market

Adjupharm Signs Supply Agreement with MediPharm Labs, Paving Way for IM Cannabis-Branded Extracts Launch in German Market

TORONTO, ON and BAD OLDESLOE, GERMANY and GLIL YAM, ISRAEL / ACCESSWIRE / April 13, 2021 / IM Cannabis Corp. ("IMC") (CSE:IMCC)(NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational cannabis sector with operations in Canada, Israel and Germany, announced that its subsidiary, Adjupharm GmbH ("Adjupharm"),... Read More...
IM Cannabis Receives DTC Eligibility as Part of NASDAQ Capital Market Listing Approval Process

IM Cannabis Receives DTC Eligibility as Part of NASDAQ Capital Market Listing Approval Process

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 26, 2021/ IM Cannabis Corp. (the "Company" or "IMC") (CSE:IMCC), a multi-country operator ("MCO") in the medical cannabis sector with operations in Israel and Germany, is pleased to announce that the Company has received confirmation from The Depository Trust Company ("DTC") that its... Read More...
IM Cannabis to Acquire Trichome in Landmark Transaction - Establishes Global Growth Platform and Leading Multi-Country Operator

IM Cannabis to Acquire Trichome in Landmark Transaction – Establishes Global Growth Platform and Leading Multi-Country Operator

Combined Company will be a fully-integrated global leader in adult-use recreational and medical cannabis markets and the only MCO operating directly in Israel, the EU, and Canada, with forecast adjusted EBITDA profitability in 2021 IMC will leverage Trichome's premium indoor cultivation to meet growing demand for premium cannabis from ... Read More...
Coming Soon.
IndexLast% Change
S&P 5004,560.770.13%Positive
Euro STOXX 504,371.490.54%Positive
FTSE 1007,423.460.43%Negative
Nikkei 22533,321.220.26%Negative

Delayed data (1h)
IndexLast% Change
S&P 5004,560.770.13%Positive
Euro STOXX 504,371.490.54%Positive
FTSE 1007,423.460.43%Negative
Nikkei 22533,321.220.26%Negative


Share this page